Electromechanical window negativity in genotyped long-QT syndrome patients: Relation to arrhythmia risk

European Heart Journal

Volumn 36, Issue 3, 2015, Pages 179-186

  Ter Bekke, Rachel M A ^a   Haugaa, Kristina H ^b   Van Den Wijngaard, Arthur ^c   Bos, J Martijn ^d,e   Ackerman, Michael J ^d,e   Edvardsen, Thor ^b   Volders, Paul G A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Department of Molecular Pharmacology and Experimental Therapeutics Long QT Syndrome Genetic Heart Rhythm Clinic   (United States)

^e MAYO CLINIC   (United States)

Author keywords

Arrhythmia; Echocardiography; Ion channels; Long QT syndrome; Sudden death

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIARRHYTHMIC AGENT; ERG1 POTASSIUM CHANNEL; ION CHANNEL; KCNE1 PROTEIN, HUMAN; KCNE2 PROTEIN, HUMAN; KCNQ1 PROTEIN, HUMAN; POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL KCNQ1; SCN5A PROTEIN, HUMAN; SODIUM CHANNEL NAV1.5; VOLTAGE GATED POTASSIUM CHANNEL;

ADULT; AORTIC VALVE CLOSURE; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EVENT FREE SURVIVAL; FEMALE; GENE MUTATION; GENOTYPE; HEART ARREST; HEART ARRHYTHMIA; HEART DENERVATION; HEART RATE; HEART VALVE SURGERY; HEART VENTRICLE FIBRILLATION; HETEROZYGOTE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LONG QT SYNDROME; LONG QT SYNDROME 1; LONG QT SYNDROME 2; LONG QT SYNDROME 3; LONG QT SYNDROME 5; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPERATION DURATION; PACEMAKER IMPLANTATION; PREDICTION; PRIORITY JOURNAL; QT INTERVAL; RISK ASSESSMENT; SUDDEN DEATH; TORSADE DES POINTES; ANALYSIS OF VARIANCE; CLINICAL TRIAL; DEATH, SUDDEN, CARDIAC; DOPPLER ULTRASONOGRAPHY; ELECTROCARDIOGRAPHY; GENETICS; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANALYSIS OF VARIANCE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CASE-CONTROL STUDIES; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; ETHER-A-GO-GO POTASSIUM CHANNELS; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; ION CHANNELS; KCNQ1 POTASSIUM CHANNEL; LONG QT SYNDROME; MALE; MUTATION; NAV1.5 VOLTAGE-GATED SODIUM CHANNEL; POTASSIUM CHANNELS, VOLTAGE-GATED; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER;

EID: 84924971417     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu370     Document Type: Article

References (22)

1. Schwartz PJ, Ackerman MJ, GeorgeALJr, Wilde AA. Impact of genetics on the clinical management of channelopathies. J Am Coll Card 2013;62:169-180.
2. ter Bekke RM, Volders PG. Arrhythmogenic mechano-electric heterogeneity in the long-QT syndrome. Prog Biophys Mol Biol 2012;110:347-358.
3. Nador F, Beria G, De Ferrari GM, Stramba-Badiale M, Locati EH, Lotto A, Schwartz PJ. Unsuspected echocardiographic abnormality in the longQTsyndrome. Diagnostic, prognostic, and pathogenetic implications. Circulation 1991;84: 1530-1542.
4. De Ferrari GM, Nador F, Beria G, Sala S, Lotto A, Schwartz PJ. Effect of calcium channel block on the wall motion abnormality of the idiopathic long QT syndrome. Circulation 1994;89:2126-2132.
5. Haugaa KH, Edvardsen T, Leren TP, Gran JM, Smiseth OA, Amlie JP. Left ventricular mechanical dispersion by tissue Doppler imaging: a novel approach for identifying high-risk individuals with long QT syndrome. Eur Heart J 2009;30:330-337.
6. Savoye C, Klug D, Denjoy I, Ennezat PV, Le Tourneau T, Guicheney P, Kacet S. Tissue Doppler echocardiography in patients with long QT syndrome. Eur J Echocardiogr 2003;4:209-213.
7. Haugaa KH, Amlie JP, Berge KE, Leren TP, Smiseth OA, Edvardsen T. Transmural differences in myocardial contraction in long-QT syndrome: mechanical consequences of ion channel dysfunction. Circulation 2010;122:1355-1363.
8. Vincent GM, Jaiswal D, Timothy KW. Effects of exercise on heart rate,QT,QTc and QT/QS2 in the Romano-Ward inherited long QT syndrome. Am J Cardiol 1991;68: 498-503.
9. Gallacher DJ, Van de Water A, van der Linde H, Hermans AN, Lu HR, Towart R, Volders PG. In vivo mechanisms precipitating torsades de pointes in a canine model of drug-induced long-QT1 syndrome. Cardiovasc Res 2007;76:247-256.
10. van der Linde HJ, Van Deuren B, Somers Y, Loenders B, Towart R, Gallacher DJ. The electro-mechanical window: a risk marker for torsade de pointes in a canine model of drug induced arrhythmias. Br J Pharmacol 2010;161:1444-1454.
11. Schwartz PJ, Crotti L. QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation 2011;124:2181-2184.
12. De Caprio L, FerroG, Cuomo S, Volpe M, Artiaco D, De Luca N, Ricciardelli B.QT/ QS2 ratio as an index of autonomic tone changes. Am J Cardiol 1984;53:818-822.
13. Lei M, Cooper PJ, Camelliti P, Kohl P. Role of the 293b-sensitive, slowly activating delayed rectifier potassium current, IKs, in pacemaker activity of rabbit isolated sinoatrial node cells. Cardiovasc Res 2002;53:68-79.
14. Aase SA, Torp H, Støylen A. Aortic valve closure: relation to tissue velocities by Doppler and speckle tracking in normal subjects. Eur J Echocardiogr 2008;9:555-559.
15. Johnson DM, Heijman J, Bode EF, Greensmith DJ, van der Linde H, Abi-Gerges N, Eisner DA, Trafford AW, Volders PG. Diastolic spontaneous calcium release from the sarcoplasmic reticulum increases beat-to-beat variability of repolarization in canine ventricular myocytes after beta-adrenergic stimulation. Circ Res 2013;112: 246-256.
16. Boudoulas H, Sohn YH,O'NeillW, BrownR,Weissler AM.TheQTgreater thanQS2 syndrome: a new mortality risk indicator in coronary artery disease. Am J Cardiol 1982;50:1229-1235.
17. Boudoulas H, Geleris P, Lewis RP, LeierCV. Effect of increased adrenergic activity on the relationship between electrical and mechanical systole. Circulation 1981;64: 28-33.
18. Kies P, Paul M, Gerss J, Stegger L, Mö nnig G, Schober O, Wichter T, Schäfers M, Schulze-Bahr E. Impaired cardiac sympathetic innervation in symptomatic patients with long QT syndrome. Eur J Nucl Med Mol Imaging 2011;38:1899-1907.
19. LindeggerN, Hagen BM, Marks AR, Lederer WJ, Kass RS. Diastolic transient inward current in long QT syndrome type 3 is caused by Ca2+ overload and inhibited by ranolazine. J Mol Cell Cardiol 2009;47:326-334.
20. Moss AJ, ZarebaW, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J, Vincent GM, Locati EH, Priori SG, Napolitano C, Medina A, Zhang L, Robinson JL, Timothy K, Towbin JA, Andrews ML. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 2000;101:616-623.
21. Guns PJ, Johnson DM,Weltens E, Lissens J. Negative electro-mechanical windows are required for drug-induced Torsades de Pointes in the anesthetized guinea pig. J Pharmacol Toxicol Methods 2012;66:125-134.
22. De Ferrari GM, Schwartz PJ. Long QT syndrome, a purely electrical disease? Not anymore. Eur Heart J 2009;30:253-255.